Clinical trial
The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)
NCT00436059 · Vejle Hospital, Other · Completed
Key facts
| NCT number | NCT00436059 |
|---|---|
| Title | The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer) |
| Official title | The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer) |
| Lead sponsor | Vejle Hospital, Other |
| Collaborators | Odense University Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | bortezomib |
| Enrollment | 20 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Feb 16, 2007 |
| Last update posted | Jul 8, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: